Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New study: does less invasive prostate treatment preserve quality of life?

NCT ID NCT06945172

First seen Jun 24, 2026 · Last updated Jun 24, 2026

Summary

This study will compare how men with intermediate-risk prostate cancer feel about their quality of life after either total prostate removal (surgery) or a less invasive treatment called focal HIFU (high-intensity focused ultrasound). About 100 sexually active men aged 40-75 will answer questionnaires 6, 12, and 24 months after treatment. The goal is to see which approach better preserves quality of life.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Clinique La Croix du Sud

    Quint-Fonsegrives, 31130, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If this trial shows that focal HIFU leads to better quality of life than total prostatectomy, it could help men with prostate cancer choose a less invasive treatment option.

What could go wrong

This is a small, early-stage study (102 participants) that only measures quality of life, not cancer control. It may not show a clear difference, and results may not apply to all patients.

Conditions

The condition(s) this trial relates to.

prostate cancer

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.